Skip to main content
OpenTrials

Clinical trial condition

Opioid-Related Disorders

Explore clinical trials studying Opioid-Related Disorders. Study availability and eligibility vary by location and protocol.

1,203 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Opioid-Related Disorders trial results

Completed

Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence

NCT00630201

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Synergy Clinical Research Center National City, California, United States
  • Amit Vijapura, MD Jacksonville, Florida, United States
  • Fidelity Clinical Research, Inc. Lauderhill, Florida, United States
View all 15 locations
View Trial Details
Completed

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

NCT01114308

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Synergy Clinical Research Center National City, California, United States
  • North County Clinical Research Oceanside, California, United States
  • Friends Research Institute Torrance, California, United States
View all 20 locations
View Trial Details
Completed

Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence

NCT00447564

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Synergy Clinical Research Center National City, California, United States
  • North County Clinical Research Oceanside, California, United States
  • Amit Vijapura, MD and Associates Jacksonville, Florida, United States
View all 18 locations
View Trial Details
Completed

OPAL: "Opiates and PhArmacoLogy"

NCT01847729

Conditions
Behavior, Chemically-Induced Disorders, Disruptive, Impulse Control, and Conduct Disorders, +7 more
Locations
  • Brest Universit Hospital Brest, France
  • CSAPA "La métairie" La Roche-sur-Yon, France
  • Morlaix Hospital Morlaix, France
  • CSAPA "Le triangle" Nantes, France
View Trial Details
Completed

ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

NCT00834080

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • Alkermes Clinical Study Site Colton, California, United States
  • Alkermes Clinical Study Site Oceanside, California, United States
  • Alkermes Clinical Study Site Lauderhill, Florida, United States
  • Alkermes Clinical Study Site Hoffman Estates, Illinois, United States
View Trial Details
Completed

Open-Label Treatment Extension Study

NCT02896296

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • Boyett Health Services Hamilton, Alabama, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Collaborative Neuroscience Network Long Beach, California, United States
  • Pacific Research Partners Oakland, California, United States
View all 29 locations
View Trial Details
Completed

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

NCT01422837

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • Assisted Recovery Centers of America Phoenix, Arizona, United States
  • Arkansas Psychiatric Clinc Little Rock, Arkansas, United States
  • Amy Solomon, MD Ben Lomond, California, United States
  • Touchstone Medical Group Clovis, California, United States
View all 31 locations
View Trial Details

Related conditions